Liabilities / Assets
98th percentile
Higher debt load relative to assets than 98% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
98th percentile
Higher debt load relative to assets than 98% of similar nonprofits.
Liabilities / Revenue
98th percentile
Higher debt load relative to revenue than 98% of similar nonprofits.
Net Margin
5th percentile
Higher net margin than 5% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
99th percentile
Faster asset growth than 99% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Assets
Up$11,896
Up $10,502 (+753%) from 2022
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Up$41,208
Up $32,200 (+357%) from 2022
Revenue
Up$19,310
Up $17,310 (+865%) from 2022
Expenses
Up$41,008
Up $37,150 (+963%) from 2022
Net Income
Down-$21,698
Down $19,840 (-1068%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To raise funds to aid in the research for a cure for cystic fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990EZSummary only. Only limited summary data is available for this year.